All Stories

  1. FGF21-inducing rare sugars for addressing obesity and alcoholism
  2. Non-nutritive sweeteners attenuate reinforced cephalic phase insulin release and impair glucose tolerance in mice
  3. Using rare sugars to address alcoholism
  4. Fibroblast growth factor 21-inducing rare sugars prevent diet-induced obesity in male BL/6 mice
  5. Activating transcription factor 4 mediates rare sugar-induced transactivation of the fibroblast growth factor 21 promoter
  6. Identification of FGF21 ‐inducing rare sugars that reduces sugar appetite in male BL /6 mice
  7. Defective medium-chain fatty acid β-oxidation in the liver alters the fat preference and induces hepatic steatosis and glucose intolerance
  8. FTO promotes weight gain via altering Kif1a splicing and axonal vesicle trafficking in AgRP neurons
  9. Promotion of obesity by fibroblast growth factor 21-oxytocin system dysfunction due to sugar-specific hyperphagia
  10. (+)-Terrein exerts anti-obesity and anti-diabetic effects by regulating the differentiation and thermogenesis of brown adipocytes in mice fed a high-fat diet
  11. MOB1 deletion in murine mature adipocytes ameliorates obesity and diabetes
  12. Impaired cardiac branched-chain amino acid metabolism in a novel model of diabetic cardiomyopathy
  13. Exposure to mouse dams to bonito broth during gestation or lactation reduces fat intake in offspring
  14. Selective β3-adrenoceptor agonist reduces energy intake and elevates GDF15 levels in lean and diet-induced obese mice
  15. Adaptive gene expression of alternative splicing variants of PGC-1α regulates whole-body energy metabolism
  16. Medium-chain triglyceride-specific appetite is regulated by the β-oxidation of medium-chain fatty acids in the liver
  17. Binding Interaction Between Lauric Acid and Cluster of Differentiation 36 Underpinned by a Fluorescence- Intensifying Assay
  18. Molecular and Neural Bases of Nutrition-Based Feeding Decision-Making
  19. Application of a novel fluorescence intensity assay: identification of distinct fatty acetates as volatile compounds that bind specifically to amino acid region 149-168 of a transmembrane receptor CD36
  20. The Hypothalamic Paraventricular Nucleus Is the Center of the Hypothalamic–Pituitary–Thyroid Axis for Regulating Thyroid Hormone Levels
  21. Disordered branched chain amino acid catabolism in pancreatic islets is associated with postprandial hypersecretion of glucagon in diabetic mice
  22. Role of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium
  23. Assessment of direct binding interaction between CD36 and its potential lipid ligands using a peptide mimic of the receptor labeled with a fluorophore
  24. Urinary FABP1 is a biomarker for impaired proximal tubular protein reabsorption and is synergistically enhanced by concurrent liver injury
  25. microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity
  26. Blood–cerebrospinal fluid barrier: another site disrupted during experimental cerebral malaria caused by Plasmodium berghei ANKA
  27. Leukotriene A4hydrolase deficiency protects mice from diet‐induced obesity by increasing energy expenditure through neuroendocrine axis
  28. The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase–leukotriene B 4 axis
  29. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels
  30. Neuronal SIRT1 regulates macronutrient-based diet selection through FGF21 and oxytocin signalling in mice
  31. SGLT1 in Pancreatic a Cells Regulates Glucagon Secretion in Mice, Possibly Explaining the Distinct Effects of SGLT2 Inhibitors on Plasma Glucagon Levels
  32. Overexpression of Nmnat3 efficiently increases NAD and NGD levels and ameliorates age-associated insulin resistance
  33. A central-acting connexin inhibitor, INI-0602, prevents high-fat diet-induced feeding pattern disturbances and obesity in mice
  34. Intraperitoneal injection of d -serine inhibits high-fat diet intake and preference in male mice
  35. Neural and Molecular Mechanisms Involved in Controlling the Quality of Feeding Behavior: Diet Selection and Feeding Patterns
  36. Zinc transporter ZIP13 suppresses beige adipocyte biogenesis and energy expenditure by regulating C/EBP-β expression
  37. Neurosecretory protein GL stimulates food intake, de novo lipogenesis, and onset of obesity
  38. Expanding frontiers in weight-control research explored by young investigators
  39. Control of Appetite and Food Preference by NMDA Receptor and Its Co-Agonist d-Serine
  40. N-methyl-d-aspartate receptor coagonistd-serine suppresses intake of high-preference food
  41. Age-Associated Weight Gain, Leptin, and SIRT1: A Possible Role for Hypothalamic SIRT1 in the Prevention of Weight Gain and Aging through Modulation of Leptin Sensitivity
  42. Miglitol protects against age-dependent weight gain in mice: A potential role of increased UCP1 content in brown adipose tissue [Rapid Communication]
  43. Overexpression of insulin receptor partially improves obese and diabetic phenotypes in <i>db/db</i> mice
  44. Dnmt3a in Sim1 Neurons Is Necessary for Normal Energy Homeostasis
  45. Protection Against High-Fat Diet-Induced Obesity inHelz2-Deficient Male Mice Due to Enhanced Expression of Hepatic Leptin Receptor
  46. Sirt1 rescues the obesity induced by insulin‐resistant constitutively‐nuclear FoxO1 in POMC neurons of male mice
  47. Elevated mitochondrial biogenesis in skeletal muscle is associated with testosterone‐induced body weight loss in male mice
  48. ATF3 expression is induced by low glucose in pancreatic α and β cells and regulates glucagon but not insulin gene transcription
  49. Hypothalamic SIRT1 prevents age-associated weight gain by improving leptin sensitivity in mice
  50. A Critical Role of Fatty Acid Binding Protein 4 and 5 (FABP4/5) in the Systemic Response to Fasting
  51. Hypothalamic ATF3 is involved in regulating glucose and energy metabolism in mice
  52. A Novel Regulatory Function of Sweet Taste-Sensing Receptor in Adipogenic Differentiation of 3T3-L1 Cells
  53. Miglitol prevents diet-induced obesity by stimulating brown adipose tissue and energy expenditure independent of preventing the digestion of carbohydrates
  54. Hepatic FoxO1 Integrates Glucose Utilization and Lipid Synthesis through Regulation of Chrebp O-Glycosylation
  55. Hypothalamic Sirt1 and regulation of food intake
  56. Necdin Controls Foxo1 Acetylation in Hypothalamic Arcuate Neurons to Modulate the Thyroid Axis
  57. FoxO1 as a double-edged sword in the pancreas: analysis of pancreas- and β-cell-specific FoxO1 knockout mice
  58. FoxO1 Gain of Function in the Pancreas Causes Glucose Intolerance, Polycystic Pancreas, and Islet Hypervascularization
  59. Overexpression of FoxO1 in the Hypothalamus and Pancreas Causes Obesity and Glucose Intolerance
  60. Induction of Sirt1 expression in the murine hypothalamic AgRP and Pomc neurons leads to lean phenotype due to decreased food intake and increased energy expenditure
  61. Genetic Defect in Phospholipase Cδ1 Protects Mice From Obesity by Regulating Thermogenesis and Adipogenesis
  62. Induction of Hypothalamic Sirt1 Leads to Cessation of Feeding via Agouti-Related Peptide
  63. Induction of Hypothalamic Sirt1 Leads to Cessation of Feeding via AgRP
  64. Roles of FoxO1 and Sirt1 in the central regulation of food intake
  65. Regulation of Pancreatic Juxtaductal Endocrine Cell Formation by FoxO1
  66. The roles of FoxO1 and Sirt1 in the regulation of food intake